Dr. André Santos | Economics | Research Excellence Award
Universidade Federal de Minas Gerais | Brazil
Dr. André Santos is a health economist and pharmacoeconomics researcher specializing in health technology assessment, cost-effectiveness analysis, and outcomes research. His Scopus record comprises 22 publications, 288 citations, and an h-index of 7, reflecting sustained international scholarly impact. He has authored influential studies on the economic burden of Chagas disease, market concentration in monoclonal antibody innovation, malaria-related quality of life, and pricing of substitute technologies. His work appears in high-impact journals including The Lancet Regional Health – Americas, PLOS ONE, Value in Health Regional Issues, and Quality of Life Research. He applies semi-Markov modeling, systematic reviews, and meta-analysis to support evidence-based reimbursement and public health policy.
300
250
200
150
100
50
0
288
22
7
Citations
Documents
h-index
Featured Publications
Cost-Effectiveness of Resmetirom for Metabolic Dysfunction-Associated Steatohepatitis in Brazil
– Value in Health Regional Issues, 2026 • Open Access
Economic Burden of Chagas Disease in Brazil: A Nationwide Cost-of-Illness Study
– The Lancet Regional Health – Americas, 2025 • Open Access